Loading clinical trials...
Loading clinical trials...
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Conditions
Interventions
Placebo
varenicline tartrate
+2 more
Locations
156
United States
Coastal Clinical Research, Inc.
Mobile, Alabama, United States
NoesisPharma Research
Phoenix, Arizona, United States
Pharmacology Research Institute
Encino, California, United States
Synergy Clinical Research of Escondido
Escondido, California, United States
Sun Valley Research Center
Imperial, California, United States
Omega Clinical Trials
La Habra, California, United States
Start Date
November 1, 2011
Primary Completion Date
January 1, 2015
Completion Date
January 1, 2015
Last Updated
June 10, 2016
NCT07441928
NCT05733767
NCT07061522
NCT06798324
NCT07013968
NCT06926608
Lead Sponsor
Pfizer
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions